Cipla posts 58% growth in net profit
Cipla posts 58% growth in net profit
Mumbai: Strong growth in both domestic and export revenues and savings in material costs helped Cipla Ltd, the country’s third-largest drugmaker by sales, post a 58.2% increase in net profit at Rs401 crore for the April-June quarter.
Total revenue grew 24% to ₹ 2,012 crore during the first quarter from ₹ 1,6
“The increase in domestic sales was largely on account of growth in the anti-asthma and antibiotics segments," the company said in a statement on Tuesday.
Shares of the company, which announced the results after trading hours, rose 1.67% on Tuesday to close at ₹ 338.55 a unit on BSE Ltd.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!